In addition, physiological levels of BMP9 (2‐5 ng/mL) promote EpCAM+ cancer stem cell (CSC) properties in Huh7 cells,59 but high levels (200 ng/mL) inhibit CD44+ CSC properties in Hep3B cells.58 Here, EPCAM is linked to cancer.